Systematic review shows superior lymph node dissection and survival in right-sided colon cancer, indicating CME's promise.
Minimally invasive CME offers superior oncological outcomes, particularly in terms of lymph node dissection and survival, without compromising short-term safety. Despite certain limitations, including insufficient long-term survival data and variability in adjuvant therapy reporting, CME represents a promising strategy for the treatment of right-sided colon cancer.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: